1 published article · Updated continuously
16 trials tracked for Dental pain: 6 in phase 3 or 4 and 1 with published results. The most-cited published study has 41 citations.
Showing the 16 most-cited and recently-updated of 16 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Non-buffered Anesthetic was associated with a significant reduction in pain scores as measured by the Behavior Pain Scale (2.24 vs. 2.61, p=0.005). This intervention did not result in statistically significant changes in heart rate (p=0.775) or diastolic blood pressure (p=0.682).
Diclofenac HPBCD demonstrated a statistically significant reduction in pain intensity (PID) on a 0-100 VAS (36.5 vs. 12.3, p<0.001). However, when administered as a subcutaneous injection (75mg/ml), the difference in pain intensity was not statistically significant (p=0.862).
Bupivacaine liposome was evaluated for opioid-free duration; the percentage of patients remaining opioid-free at 24, 48, and 72 hours remained consistent at 19% and 12% respectively across the study period.
The 5% calcium sodium phosphosilicate toothpaste did not produce statistically significant changes in evaporative air sensitivity (p=0.6674 at 7 days; p=0.3628 at 15 days) or cold water sensitivity (p=0.9759) on a Visual Analog Scale (VAS).
AI synthesis of 0 cited trials, updated Nov 6, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
